Sarepta Therapeutics | SRPT - Trade Debtors


Sarepta Therapeutics reported $398.23M in Trade Debtors for its fiscal quarter ending in December of 2025.





Trade Debtors Change Date
Acadia Pharmaceuticals USD 148.23M 8.79M Dec/2025
Agios Pharmaceuticals USD 10.58M 5.55M Dec/2025
Alnylam Pharmaceuticals USD 777.57M 187.2M Dec/2025
Amgen USD 9.57B 1.08B Dec/2025
BioCryst Pharmaceuticals USD 106.82M 15.49M Dec/2025
Biogen USD 1.85B 234M Sep/2025
BioMarin Pharmaceutical USD 908.21M 117.95M Dec/2025
Capricor Therapeutics USD 59K 0 Dec/2025
Daiichi Sankyo JPY 695.95B 79.1B Dec/2025
Eli Lilly USD 19.46B 2.25B Sep/2025
Esperion Therapeutics USD 140.19M 21.21M Dec/2025
Gilead Sciences USD 4.91B 182M Dec/2025
Incyte USD 1.02B 128.52M Dec/2025
Insmed USD 140.86M 75.6M Dec/2025
Ionis Pharmaceuticals USD 66M 41.39M Dec/2025
Moderna USD 184M 862M Dec/2025
Nektar Therapeutics USD 1.78M 1.12M Dec/2025
Neurocrine Biosciences USD 686.8M 41.2M Dec/2025
Novavax USD 106.45M 72.27M Dec/2025
Pfizer USD 18.12B 2.02B Sep/2025
PTC Therapeutics USD 181.62M 21.45M Dec/2025
Regeneron Pharmaceuticals USD 5.74B 54M Dec/2025
Roche Holding CHF 11.9B 460M Dec/2025
Sangamo BioSciences USD 581K 110K Jun/2024
Sanofi EUR 482M 85M Mar/2026
Sarepta Therapeutics USD 398.23M 2.49M Dec/2025
Tectonic Therapeutic USD 0 270K Dec/2023
Ultragenyx Pharmaceutical USD 112.54M 11.92M Sep/2025
Vertex Pharmaceuticals USD 2.05B 106.4M Dec/2025